​Thank you for your question about CMS506v3 "Safe Use of Opioids - Concurrent Prescribing​." You are correct that the measure should not include opioids completed during the inpatient visit. The eCQM specifications follow QDM v5.5 standards, which state that the “Medication, Discharge” datatype used in the spec should require documentation of medications that should be taken by or given to the patient after being discharged from an inpatient encounter. Since your reports are showing completed opioids as an active prescription at discharge, you may find that revising your workflow (how you are indicating active and completed medications) will solve the issue. Please let us know if you have additional questions.​

We have found that opioid prescriptions completed during an inpatient encounter are counting as an active prescription at discharge. The patient is not going home on this prescription, so it doesn't seem like it should count as an active medication. Are completed prescriptions going to be excluded in future specs?